Rapid Sequence Intubation at the Emergency Department

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

All patients undergoing emergent endotracheal intubation (RSI) at the Emergency Department will be screened for inclusion in this clinical study. The indication of endotracheal intubation is an exclusively clinical decision and is not affected by this study protocol in any aspect.

If fulfilling the In- and exclusion criteria's, patient will be randomly assigned to one of two groups

1. C-MAC Videolaryngoscope in appropriate size
2. conventional endotracheal intubation using Macintosh Blade in appropriate size

Randomization (1:1) will be based on computer-generated codes maintained in sequentially numbered opaque envelopes that will be opened immediately before randomization.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ETI During Intubation

NCT02295618

Intubation Cardiac Arrest

COMPLETED NA

Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management

NCT01710891

Acute Respiratory Distress

COMPLETED PHASE4

Intubation During Resuscitation

NCT02277951

Intubation Cardiopulmonary Resuscitation

COMPLETED

Endotracheal Intubation in Prehospital Scenario

NCT02681835

Endotracheal Intubation

COMPLETED NA

Pediatric Endotracheal Intubation

NCT02291653

Cardiac Arrest Intubation, Endotracheal

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

conventional endotracheal intubation

Patients assigned to this group will be intubated using conventional Macintosh blade in adequate size.

Group Type ACTIVE_COMPARATOR

Macintosh blade

Intervention Type DEVICE

conventional endotracheal intubation

C-MAC

Patients assigned to this group will be intubated using C-MAC videolaryngoscope in adequate size.

Group Type ACTIVE_COMPARATOR

C-MAC videolaryngoscope

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Macintosh blade

conventional endotracheal intubation

Intervention Type DEVICE

C-MAC videolaryngoscope

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients requiring emergency Rapid Sequence Intubation at the emergency department
* Male and Female subjects 18 years to 99 years of age
* Written confirmation by a physician not involved in this study
* Written informed consent by the participant (obtained afterwards)
* Patient not showing remarkable rejection in participation in this study

Exclusion Criteria

* Maxilla-Facial trauma
* Immobilized cervical spine
* Indication for fiberoptic guided intubation (known difficult airway)
* Ongoing Cardio-Pulmonary-Resuscitation (CPR)
* Involvement in any other clinical trial during the course of this trial, within a period of 30 days prior to its beginning or 30 days after its completion
* Severe or immediately life-treating injury requiring immediate medical treatment

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No